Individuals Stopping Weight-Loss Jabs Regain Weight Four Times Faster Compared to Dieters

Illustration of medical syringe and scale
Obesity treatment often requires long-term strategies.

A recent study suggests that people who come off blockbuster slimming jabs like Wegovy and Mounjaro can put back on shed pounds far faster than those who end traditional lifestyle programs.

Findings released in a leading health publication demonstrates that while obese individuals frequently drop about a fifth of their body weight while using the jabs, the mass is regained at an estimated rate of nearly a kilo each month upon discontinuation.

"People buying these treatments need to be informed of the danger of fast rebound weight gain when the medication is stopped," stated lead investigator Dr. Susan Jebb.

This pace of regain means a return to starting mass in about one and a half years.

Analyzing Therapies

The analysis, which looked at dozens of trials involving thousands of patients, contrasted the results of these new drugs with older methods.

Researchers point out that individuals who lose weight through diet and exercise usually have a more gradual creep back—approximately 100 grams monthly—after stopping.

Explaining the Rapid Rebound

Experts suggest the way of the jabs is key to understanding the amplified regain.

These medications mimic a body's own chemical called GLP-1, which controls feelings of fullness.

"Artificially providing GLP-1 levels several times higher than the body's typical production could lead to the body to generate a reduced amount of its own natural hormone, and may also lessen responsiveness to its effects," said Dr. Adam Collins, a dietetics specialist.

"Discontinuation of this hormone supplement leads to appetite is unsuppressed, making binge eating a significant risk."

An Ongoing Issue?

Medical guidelines suggest the injections for individuals with weight-linked health risks, accompanied by recommended diet and exercise modifications.

Many experts say that, given the significant potential of weight regain, the treatment might need to be long-term.

This opinion is supported by drug manufacturers, who note that the findings "highlight the long-term character of excess weight," similar to managing diseases like high blood pressure.

User Testimonies

Individuals who have stopped the medication describe a intense return of hunger.

"It was like a trigger flipping and you become ravenous," described an individual.

The struggle is exacerbated if users have not developed permanent dietary or behavioural changes during therapy.

Widespread Use

Figures indicate that millions of adults in the UK have tried weight-loss jabs in the past year, with demand continuing to grow.

  • Use is higher among females than males.
  • The middle-aged demographic shows the greatest usage rates.
  • A large proportion obtain the medications through private healthcare rather than the NHS.

Ultimately, clinicians emphasize that while the jabs are effective tools for shedding pounds, they are not a magic solution and maintained weight loss hinges on integrated behavioural changes.

Brian Brooks
Brian Brooks

Data scientist and tech enthusiast with a passion for demystifying complex AI concepts for a broader audience.